Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Launches Integra Mozaik(TM) Moldable Morsels for Bone Grafting Procedures
PLAINSBORO, N.J., March 10, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of Integra Mozaik™ Moldable Morsels bone void filler, which will be available in four sizes. Integra Mozaik™ Moldable Morsels expands the successful Integra
View HTML
Toggle Summary Integra LifeSciences Launches Portfolio of Advanced Orthobiologics for Spine Surgery
PLAINSBORO, N.J., March 9, 2010 (GLOBE NEWSWIRE) -- Integra Lifesciences Holdings Corporation (Nasdaq:IART) announced today that it has created a portfolio of advanced bone grafting products, which will be sold in conjunction with its Integra Spine implants, providing spine surgeons a comprehensive
View HTML
Toggle Summary Integra LifeSciences to Present at Three Conferences in March
Raymond James Institutional Investors Conference Canaccord Adams Musculoskeletal Conference Barclays Capital Healthcare Conference PLAINSBORO, N.J., March 1, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at three conferences in
View HTML
Toggle Summary Integra LifeSciences Announces the Newest Additions to its Portfolio of Hydrocephalus Management Products: The OSV II(R) Lumbar and OSV II(R) Low Flow Lumbar Self-Adjusting Valves
PLAINSBORO, N.J., March 1, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of two new valve systems for the treatment of hydrocephalus, the OSV II ® Lumbar and the OSV II ® Low Flow Lumbar Valve Systems.  The new line of lumbar
View HTML
Toggle Summary Integra LifeSciences Reports Fourth Quarter and Full Year 2009 Financial Results
Revenues for the Fourth Quarter and Full Year Increased to $184 Million and $682 Million Cash Flow From Operations for the Fourth Quarter and Full Year Increased to $47 Million and $143 Million PLAINSBORO, N.J., March 1, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation
View HTML
Toggle Summary Integra LifeSciences Donates Over $300,000 Worth of Medical Instruments to Haiti Earthquake Relief Efforts
PLAINSBORO, N.J., Feb. 2, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has donated over $300,000 worth of Jarit® and Miltex® surgical instruments to Direct Relief International, a non-profit, non-sectarian humanitarian assistance
View HTML
Toggle Summary Integra LifeSciences to Present at the Deutsche Bank 2010 Small and Mid Cap Conference
PLAINSBORO, N.J., Feb. 1, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the Deutsche Bank 2010 Small and Mid Cap Conference in Naples, Florida. Mr. John B. Hennenman, III, Executive Vice President and Chief Financial Officer
View HTML
Toggle Summary Integra LifeSciences Announces First Two-Level Surgery With Paramount(R) Pedicle Screw System for Minimally Invasive Spine Surgery
PLAINSBORO, N.J., Jan. 25, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today that the first two-level surgery using the Paramount® Pedicle Screw System for minimally invasive spine surgery under Integra Spine's ownership was performed by Dr.
View HTML
Toggle Summary Integra LifeSciences Announces First Surgery With Coral Spinal System for Minimally Invasive Spine Surgery
PLAINSBORO, N.J., Jan. 22, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today that the first clinical application of the Coral™ Spinal System for minimally invasive spine surgery was performed by Dr. Morteza Farr from Santa Cruz, California. Dr.
View HTML
Toggle Summary Integra LifeSciences to Host Fourth Quarter 2009 Earnings Results Conference Call on March 1, 2010
PLAINSBORO, N.J., Jan. 19, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter and full year 2009 financial results and update its financial guidance for 2010 on Monday, March 1, 2010. The company has scheduled a conference call for 8:30
View HTML